Literature DB >> 9327246

Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals.

H Bello1, G Gonzalez, M Dominguez, R Zemelman, A Garcia, S Mella.   

Abstract

The activity of some third generation cephalosporins, aztreonam, imipenem, ciprofloxacin, and amikacin against isolates of Acinetobacter baumannii of various biotypes has been studied. The isolates, independently of the biotype, exhibited a broad multiresistance against cephalosporins. Ceftazidime was the most active and cefoperazone the least active compound. Aztreonam also showed low activity and no imipenem-resistant strains were found. Ciprofloxacin and amikacin were somewhat more active than cephalosporins, but resistant isolates were also frequent. Isolates of Biotypes 9 and 8 exhibited broader multiresistance than those of Biotype 6 and "other."

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327246     DOI: 10.1016/s0732-8893(97)00074-6

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  3 in total

1.  Alterations in surface hydrophobicity of Acinetobacter baumannii induced by meropenem.

Authors:  A Hostacká
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

2.  Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains.

Authors:  B Heinemann; H Wisplinghoff; M Edmond; H Seifert
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

3.  Characteristics of clinical Acinetobacter spp. strains.

Authors:  A Hostacká; L Klokocníková
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.